Clodivac Suspension for Injection. Diphtheria and tetanus adsorbed, with reduced antigen content.

País: Malta

Língua: inglês

Origem: Medicines Authority

Ingredientes ativos:

DIPHTHERIA TOXOID, TETANUS TOXOID

Disponível em:

IBSS Biomed S.A. AL. Sosnowa 8, 30-224 Krakow, Poland

Código ATC:

J07AM51

DCI (Denominação Comum Internacional):

DIPHTHERIA TOXOID 5 IU TETANUS TOXOID 40 IU

Forma farmacêutica:

SUSPENSION FOR INJECTION

Composição:

DIPHTHERIA TOXOID 5 IU TETANUS TOXOID 40 IU

Tipo de prescrição:

POM

Área terapêutica:

VACCINES

Resumo do produto:

Licence number in the source country: Poland - R/0038

Status de autorização:

Authorised

Data de autorização:

2012-09-06

Folheto informativo - Bula

7U004E
1
PACKAGE LEAFLET: INFORMATION FOR THE USER
CLODIVAC, suspension for injection
Diphtheria and tetanus vaccine, adsorbed, reduced antigen content
Not less than 40 IU of tetanus toxoid and not less than 5 IU of
diphtheria toxoid/0.5 ml;
1 dose (0.5 ml)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS VACCINE
BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor, pharmacist or
nurse.

This vaccine has been prescribed for you only. Do not pass it on to
others.

If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible
side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1.
What Clodivac is and what it is used for
2.
What do you need to know before you use Clodivac
3.
How to use Clodivac
4.
Possible side effects
5.
How to store Clodivac
6.
Contents of the pack and other information
1.
WHAT CLODIVAC IS AND WHAT IT IS USED FOR
Clodivac is a vaccine used to protect against two diseases: tetanus
and diphtheria caused by
_Clostridium tetani_ and _Corynebacterium diphtheriae. _Active
substances of the vaccine are tetanus
toxoid and diphtheria toxoid (non-infectious components derived from
bacteria). After vaccine
administration the organism produces antibodies to protect against
these diseases.
The vaccine is used for active immunisation
of children over 7 years of age, adolescents and adults
against tetanus and diphtheria.
_ _
Basic vaccination

individuals over 7 years of age who have not received the basic
vaccination against diphtheria
and tetanus (i.e. mandatory vaccination according to the National
Immunization Program).
Booster vaccination

children over 7 years of age who have not received booster dose of
DTPa at the age of 6 (in
case of contraindication for pertussis vaccination)

adolescents at age of 14 and 19,

adults who received a complete course of basic vaccination against
tetanus and diphtheria
(bo